MODULAR MEDICAL INC (MODD) Stock Price, Quote, News and Overview
NASDAQ:MODD - Nasdaq - US60785L2079 - Common Stock - Currency: USD
MODD Quote, Performance and Key Statistics
NASDAQ:MODD (2/20/2025, 2:41:14 PM)
1.09
-0.02 (-1.8%)
The current stock price of MODD is 1.09 USD. In the past month the price decreased by -6.72%. In the past year, price decreased by -37.64%.
MODD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.48 | 230.70B | ||
| ISRG | INTUITIVE SURGICAL INC | 82.67 | 216.13B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.88 | 154.94B | ||
| SYK | STRYKER CORP | 31.69 | 147.26B | ||
| MDT | MEDTRONIC PLC | 16.39 | 112.24B | ||
| BDX | BECTON DICKINSON AND CO | 16.36 | 65.33B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.52 | 44.07B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.52 | 42.10B | ||
| IDXX | IDEXX LABORATORIES INC | 40.36 | 37.18B | ||
| DXCM | DEXCOM INC | 53.62 | 34.56B | ||
| RMD | RESMED INC | 26.36 | 34.23B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.2 | 23.44B |
Related stock screener links
About MODD
Company Profile
Modular Medical, Inc. is a development stage company, which engages in the provision of insulin pump technology. The company is headquartered in San Diego, California and currently employs 39 full-time employees. The company went IPO on 2006-01-13. The firm is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. Its product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include two parts - one reusable, one disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; disposable portion removable at any time from an adhesive-backed retainer, which remains in place, and no external controller required, no charging and no battery replacement. MODD1 comes with a variety of methods for the patient to wear the pump. Options include a base plate with adhesive for attaching to the body that has features for holding the pump to the patient, and overwraps to hold the product to the patient.
Company Info
MODULAR MEDICAL INC
16772 West Bernardo Drive
San Diego CALIFORNIA US
Employees: 40
Company Website: https://www.modular-medical.com/
Investor Relations: http://modular-medical.com/investor
Phone: 18588003500
MODULAR MEDICAL INC / MODD FAQ
What is the stock price of MODULAR MEDICAL INC today?
The current stock price of MODD is 1.09 USD. The price decreased by -1.8% in the last trading session.
What is the ticker symbol for MODULAR MEDICAL INC stock?
The exchange symbol of MODULAR MEDICAL INC is MODD and it is listed on the Nasdaq exchange.
On which exchange is MODD stock listed?
MODD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MODULAR MEDICAL INC stock?
7 analysts have analysed MODD and the average price target is 8.16 USD. This implies a price increase of 648.62% is expected in the next year compared to the current price of 1.09. Check the MODULAR MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MODULAR MEDICAL INC worth?
MODULAR MEDICAL INC (MODD) has a market capitalization of 44.33M USD. This makes MODD a Nano Cap stock.
How many employees does MODULAR MEDICAL INC have?
MODULAR MEDICAL INC (MODD) currently has 40 employees.
What are the support and resistance levels for MODULAR MEDICAL INC (MODD) stock?
MODULAR MEDICAL INC (MODD) has a support level at 1.09 and a resistance level at 2.33. Check the full technical report for a detailed analysis of MODD support and resistance levels.
Should I buy MODULAR MEDICAL INC (MODD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MODD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MODD, evaluating the profitability, health, valuation and growth aspects
- MODULAR MEDICAL INC (MODD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MODULAR MEDICAL INC (MODD) Sales and EPS estimates to see what analysts future expectations are.
- MODULAR MEDICAL INC (MODD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MODULAR MEDICAL INC (MODD) Insider and Institutional Ownership to learn about the owners and their transactions.
- MODULAR MEDICAL INC (MODD) Stock Chart to make your own analysis
- MODULAR MEDICAL INC (MODD) Latest news and press-releases to stay up to date.
Does MODULAR MEDICAL INC (MODD) stock pay dividends?
MODD does not pay a dividend.
What is the Price/Earnings (PE) ratio of MODULAR MEDICAL INC (MODD)?
MODULAR MEDICAL INC (MODD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.63).
What is the Short Interest ratio of MODULAR MEDICAL INC (MODD) stock?
The outstanding short interest for MODULAR MEDICAL INC (MODD) is 0.85% of its float. Check the ownership tab for more information on the MODD short interest.
MODD Technical Analysis
MODD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MODD. While MODD seems to be doing ok healthwise, there are quite some concerns on its profitability.
MODD Financial Highlights
Over the last trailing twelve months MODD reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS increased by 40% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -212.55% | ||
| ROE | -269.56% | ||
| Debt/Equity | 0 |
MODD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to MODD. The Buy consensus is the average rating of analysts ratings from 7 analysts.